Global Cancer Diagnostics Device Market to Grow 18.07% by 2020 - Key Vendors are Agilent Technologies, Qiagen & Roche Diagnostics - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Cancer Diagnostics Device Market 2016-2020" report to their offering.

The report forecasts the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

A trend which will definitely boost market growth is product approvals and launches. The significant focus on cancer diagnosis has led to the development of novel cancer diagnostic devices in the market. Many of these products have received approval from regulatory agencies such as the FDA and Health Canada. The availability of these advanced tests and associated diagnostic devices has allowed medical facilities to adopt them for cancer diagnosis.

According to the report, a key growth driver is the demand for personalized medicines. The production of personalized drugs depends on the identification and study of protein and gene expressions. These drugs are customized based on an individual's protein or genetic profiles. Personalized medicines have high demand in oncology therapy since conventional cancer drug therapies fail to achieve desired patient outcomes.

Further, the report states that one challenge that could impact market growth is the high cost of developing companion diagnostics.

Key vendors:

  • Abbott Diagnostics
  • Agilent Technologies
  • BD
  • bioMérieux
  • Qiagen
  • Roche Diagnostics

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Cancer statistics

PART 06: Market landscape

PART 07: Reimbursement and coverage: An overview

PART 08: Cancer diagnostic devices: Pricing scenario

PART 09: Market segmentation by product

PART 10: Market segmentation by cancer type

PART 11: Geographical segmentation

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

PART 18: Key vendors

PART 19: Appendix

For more information visit http://www.researchandmarkets.com/research/zrvp5c/global_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics